Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine.
Saved in:
| Title: | Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccine. |
|---|---|
| Authors: | Stokdyk K; Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States., Sahoo A; Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States., Gangadhara S; Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States., Williams LD; Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Styles TM; Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States., Hellman CA; Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Zhang L; Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Odeh AJ; Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Flaherty S; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Shen X; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Rahman MA; Animal Models and Retroviral Vaccines Section, Basic Research Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, United States., Norton EB; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, United States., Franchini G; Animal Models and Retroviral Vaccines Section, Basic Research Laboratory, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD, United States., Montefiori D; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Kozlowski PA; Department of Microbiology, Immunology and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States., Tomaras GD; Duke Center for Human Systems Immunology, Duke University School of Medicine, Durham, NC, United States.; Department of Surgery, Duke University Medical Center, Durham, NC, United States., Amara RR; Emory National Primate Research Center, Emory University, Atlanta, GA, United States.; Department of Microbiology and Immunology, Emory School of Medicine, Emory University, Atlanta, GA, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jan 21; Vol. 16, pp. 1706958. Date of Electronic Publication: 2026 Jan 21 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2025.1706958 |
